Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update

Thipprapai Mahasaksiri, Chaninan Kositkuljorn, Tanaporn Anuntrangsee, Poonkiat Suchonwanit Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Poonkiat SuchonwanitDivision of Dermatology, Department of Medic...

Full description

Bibliographic Details
Main Authors: Mahasaksiri T, Kositkuljorn C, Anuntrangsee T, Suchonwanit P
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/application-of-topical-immunotherapy-in-the-treatment-of-alopecia-area-peer-reviewed-article-DDDT
id doaj-3ff9c72f88ca46b280a4096cd18390db
record_format Article
spelling doaj-3ff9c72f88ca46b280a4096cd18390db2021-03-23T20:26:22ZengDove Medical PressDrug Design, Development and Therapy1177-88812021-03-01Volume 151285129863322Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and UpdateMahasaksiri TKositkuljorn CAnuntrangsee TSuchonwanit PThipprapai Mahasaksiri, Chaninan Kositkuljorn, Tanaporn Anuntrangsee, Poonkiat Suchonwanit Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Poonkiat SuchonwanitDivision of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchathewi, Bangkok, 10400, ThailandTel +66 2-2011141Fax +66 2-201-1211 Ext 4Email poonkiat@hotmail.comAbstract: Treatment of extensive or recalcitrant alopecia areata (AA) is a major clinical challenge. Even after thorough investigation of several medications, its treatment outcomes have remained unsatisfactory. While there is no US Food and Drug Administration-approved medication for AA yet, topical immunotherapy has been a well-documented treatment option. Dinitrochlorobenzene, squaric acid dibutylester, and diphenylcyclopropenone are three substances that have demonstrated efficacy in the treatment of extensive or recalcitrant AA. Despite being commonly used, the mechanism underlying topical immunotherapy is not well-elucidated and a wide range of clinical efficacies have been reported in the literature. The aim of this review was to summarize and update the pharmacology, mechanism of action, therapeutic efficacy, and tolerability of topical immunotherapy in the treatment of AA.Keywords: contact sensitizers, dinitrochlorobenzene, diphencyprone, diphenylcyclopropenone, hair loss, squaric acid dibutylesterhttps://www.dovepress.com/application-of-topical-immunotherapy-in-the-treatment-of-alopecia-area-peer-reviewed-article-DDDTcontact sensitizersdinitrochlorobenzenediphencypronediphenylcyclopropenonehair losssquaric acid dibutylester
collection DOAJ
language English
format Article
sources DOAJ
author Mahasaksiri T
Kositkuljorn C
Anuntrangsee T
Suchonwanit P
spellingShingle Mahasaksiri T
Kositkuljorn C
Anuntrangsee T
Suchonwanit P
Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
Drug Design, Development and Therapy
contact sensitizers
dinitrochlorobenzene
diphencyprone
diphenylcyclopropenone
hair loss
squaric acid dibutylester
author_facet Mahasaksiri T
Kositkuljorn C
Anuntrangsee T
Suchonwanit P
author_sort Mahasaksiri T
title Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
title_short Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
title_full Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
title_fullStr Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
title_full_unstemmed Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
title_sort application of topical immunotherapy in the treatment of alopecia areata: a review and update
publisher Dove Medical Press
series Drug Design, Development and Therapy
issn 1177-8881
publishDate 2021-03-01
description Thipprapai Mahasaksiri, Chaninan Kositkuljorn, Tanaporn Anuntrangsee, Poonkiat Suchonwanit Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Poonkiat SuchonwanitDivision of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchathewi, Bangkok, 10400, ThailandTel +66 2-2011141Fax +66 2-201-1211 Ext 4Email poonkiat@hotmail.comAbstract: Treatment of extensive or recalcitrant alopecia areata (AA) is a major clinical challenge. Even after thorough investigation of several medications, its treatment outcomes have remained unsatisfactory. While there is no US Food and Drug Administration-approved medication for AA yet, topical immunotherapy has been a well-documented treatment option. Dinitrochlorobenzene, squaric acid dibutylester, and diphenylcyclopropenone are three substances that have demonstrated efficacy in the treatment of extensive or recalcitrant AA. Despite being commonly used, the mechanism underlying topical immunotherapy is not well-elucidated and a wide range of clinical efficacies have been reported in the literature. The aim of this review was to summarize and update the pharmacology, mechanism of action, therapeutic efficacy, and tolerability of topical immunotherapy in the treatment of AA.Keywords: contact sensitizers, dinitrochlorobenzene, diphencyprone, diphenylcyclopropenone, hair loss, squaric acid dibutylester
topic contact sensitizers
dinitrochlorobenzene
diphencyprone
diphenylcyclopropenone
hair loss
squaric acid dibutylester
url https://www.dovepress.com/application-of-topical-immunotherapy-in-the-treatment-of-alopecia-area-peer-reviewed-article-DDDT
work_keys_str_mv AT mahasaksirit applicationoftopicalimmunotherapyinthetreatmentofalopeciaareataareviewandupdate
AT kositkuljornc applicationoftopicalimmunotherapyinthetreatmentofalopeciaareataareviewandupdate
AT anuntrangseet applicationoftopicalimmunotherapyinthetreatmentofalopeciaareataareviewandupdate
AT suchonwanitp applicationoftopicalimmunotherapyinthetreatmentofalopeciaareataareviewandupdate
_version_ 1724205602604843008